Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes

被引：0

作者：

Hermansen, K. ^{[1
]}

Heller, S. ^{[2
]}

Andersen, M. ^{[3
]}

Russell-Jones, D. L. ^{[4
]}

机构：

[1] Aarhus Univ Hosp, Dept Endocrinol & Metab, Aarhus, Denmark

[2] Sch Med & Biomed Sci, Sheffield, S Yorkshire, England

[3] Statgrp DK, Copenhagen, Denmark

[4] Royal Surrey Country Hosp NHS Trust, Dept Endocrinol & Diabet, Guildford, Surrey, England

来源：

DIABETOLOGIA | 2009年 / 52卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

914

引用

页码：S359 / S359

页数：1

共 50 条

[41] Once-daily dosing of insulin detemir is associated with lower risk of hypoglycaemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
Shaw, J. E.
Larsen, J.
Pedersen, C. B.
Tang-Fui, S.
[J]. DIABETOLOGIA, 2008, 51 : S391 - S391
[42] No correlation between weight gain and number of hypoglycemic events in patients with type 2 diabetes treated with insulin detemir as compared to NPH insulin
Davies, Melanie
Derezinski, Tadeusz
Kim, Hansoo
Clauson, Per
[J]. DIABETES, 2006, 55 : A466 - A466
[43] No correlation between weight gain and number of hypoglycaemic events in patients with type 2 diabetes treated with insulin detemir as compared to NPH insulin
Derezinski, T.
Davies, M.
Kim, H.
Clauson, P.
[J]. DIABETOLOGIA, 2006, 49 : 94 - 94
[44] PREDICTIVE 303 Study: insulin detemir improves glycaemic control, weight and hypoglycaernia in patients previously treated with insulin glargine or NPH insulin
Koenen, C.
Meneghini, L.
Weng, W.
Selam, J.-L.
[J]. DIABETOLOGIA, 2007, 50 : S403 - S403
[45] Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes A systematic review and meta-analysis
Szypowska, Agnieszka
Golicki, Dominik
Groele, Lidia
Pankowska, Ewa
[J]. POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2011, 121 (7-8): : 237 - 246
[46] A COMPARISON OF INSULIN ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES INITIATING THERAPY WITH INSULIN DETEMIR FLEXPEN® OR NPH INSULIN IN A VIAL
Buysman, E.
Aagren, M.
Liu, F.
Bouchard, J.
Conner, C.
[J]. VALUE IN HEALTH, 2011, 14 (07) : A481 - A481
[47] Lower incidence of nocturnal hypoglycaemia in patients with Type 2 diabetes treated with insulin glargine compared with NPH insulin, given as a combination regimen with oral agents.
Benedetti, MM
Hamburg, E
Dressler, A
Ziemen, M
[J]. DIABETOLOGIA, 2002, 45 : A259 - A259
[48] Treatment with insulin detemir provides improved glycemic control and less weight gain compared to NPH insulin in people with diabetes
Garber, AJ
Olsen, KJ
Draeger, E
[J]. DIABETES, 2004, 53 : A125 - A125
[49] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
Dailey, G.
Aurand, L.
Garg, S.
[J]. DIABETOLOGIA, 2011, 54 : S262 - S262
[50] Lower risk of nocturnal hypoglycaemia with insulin detemir versus NPH insulin in people with diabetes: a meta-analysis of controlled phase III trials
Nattrass, M
Kim, H
Draeger, E
[J]. DIABETOLOGIA, 2004, 47 : A326 - A327

← 1 2 3 4 5 →